ENTITY
SillaJen Inc

SillaJen Inc (215600 KS)

52
Analysis
Health CareSouth Korea
SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.
more
bullishNCSOFT Corp
17 Sep 2017 20:38

NCsoft Valuation Study - Lineage M Isn't a RPG, Rather a Digital Currency to Mine

NCsoft Corp (036570 KS) is one of the five stocks that have consistently ranked top in Naver Finance's most searched stock list in the past three...

Logo
524 Views
Share
01 Jun 2017 14:39

Summary of KOSPI200 & KOSDAQ150 Upcoming Reshuffle

As I said in my earlier comment, Samsung Biologics Co., Ltd (207940 KS) seems to be benefiting a lot from its inclusion in KOSPI200 index. Perhaps...

Logo
2.3k Views
Share
bullishSillaJen Inc
29 Nov 2016 05:36

SillaJen IPO Part 5 - Revenue & Valuation Estimates with Pexa-Vec's First Commercialization Year

We need to examine the size of SillaJen's expected sales in 2020, which is the reference year for its entire valuation. With an assumption that...

Logo
442 Views
Share
bullishSillaJen Inc
26 Nov 2016 03:48

SillaJen IPO Part 4 - IPO Price & Post-IPO Risks

SillaJen IPO price was set at ₩15,000, the lowest end of the indicative price band, after conducting the demand survey from (Nov 23-24) the...

Logo
372 Views
Share
bullishSillaJen Inc
21 Nov 2016 13:33

SillaJen IPO Part 3 - Competitive Strengths of Product (Pexa-Vec)

* In Part 3 (as below), I summarized the competitive strengths of product (Pexa-Vec).SillaJen's Pexa-Vec is an advanced liver cancer treatment...

Logo
339 Views
Share
x